The Diagnostic Process: Biopsy, MRI, and Blood Tests
At a Glance
Diagnosing Eosinophilic Fasciitis requires looking deep beneath the skin. The most critical step is a full-thickness biopsy that includes the fascia, often guided by an MRI to pinpoint inflammation. Standard skin punch biopsies typically miss the disease.
Diagnosing Eosinophilic Fasciitis (EF) requires looking beneath the surface of the skin. Because EF affects the deep layers of connective tissue, standard skin tests often miss the problem entirely. A definitive diagnosis usually involves a combination of specialized imaging, deep tissue sampling, and blood analysis after reviewing your physical symptoms [1][2][3].
The Critical Need for a Full-Thickness Biopsy
The most important step in confirming EF is a full-thickness biopsy, sometimes called an en bloc biopsy [1][4].
A common reason for misdiagnosis is the use of a “punch biopsy”—a shallow, circular sample that only captures the top layers of skin. Since EF is a disease of the fascia (the deep tissue wrapping around muscles), a shallow biopsy will often come back as “normal” or suggest a different condition [1].
To get an accurate result, the surgeon must take a wedge of tissue that includes:
- The skin
- The fat layer (subcutaneous tissue)
- The fascia (the primary target)
- A small piece of the underlying muscle [1]
Pathologists look for specific markers in this sample, particularly eosinophilic infiltration (an accumulation of a specific type of white blood cell) and fibrous thickening within the fascia itself [5][6].
The Role of MRI in Diagnosis
Magnetic Resonance Imaging (MRI) has become a vital, non-invasive tool for diagnosing EF [1][2].
In a person with EF, an MRI—specifically an “enhanced” MRI using contrast—can show:
- Fascial Thickening: The fascia appears much thicker than normal [1].
- Fascial Enhancement: The inflamed fascia “lights up” on the scan, showing active inflammation [1][3].
Beyond confirming the diagnosis, the MRI helps your medical team “map out” the best location for a biopsy. By identifying exactly where the inflammation is most active, doctors can ensure the biopsy sample is taken from an area likely to provide clear answers [1][7].
Bloodwork and Lab Markers
While blood tests alone cannot diagnose EF, they provide important supporting evidence to guide your treatment plan. However, it is important to note that these markers are not always present in every patient, especially if treatment has already begun [8][9].
- Peripheral Eosinophilia: This is an abnormally high count of eosinophils (white blood cells) in your blood [5][9]. It is a classic sign of EF but can disappear quickly once you start taking steroids [10].
- Hypergammaglobulinemia: This refers to high levels of antibodies (gamma globulins) in the blood, indicating that the immune system is overactive [11][12].
- Inflammatory Markers: Tests like the Erythrocyte Sedimentation Rate (ESR) or C-Reactive Protein (CRP) may be elevated, showing that there is systemic inflammation in the body [13].
If your blood work comes back normal but your physical symptoms and MRI suggest EF, your doctor will likely still proceed with a biopsy, as clinical signs and tissue samples are the most reliable diagnostic “gold standards” [2][14].
Common questions in this guide
Why do I need a full-thickness biopsy instead of a regular skin biopsy for EF?
What will an MRI show if I have Eosinophilic Fasciitis?
Can blood tests diagnose Eosinophilic Fasciitis?
Will starting steroids affect my blood test results?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my biopsy a full-thickness 'en bloc' sample that included the muscle fascia, or just a skin-level punch biopsy?
- 2.Did my MRI show specific 'fascial enhancement' or thickening that helps confirm EF?
- 3.Was my eosinophil count elevated when I first presented with symptoms, or was it checked after I started medications?
- 4.Does my blood work show hypergammaglobulinemia or an elevated ESR, and what do these mean for my diagnosis?
- 5.Is the pathologist who reviewed my biopsy familiar with the specific features of eosinophilic fasciitis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Diagnosis and treatment of early eosinophilic fasciitis: a case report.
Ma J, Cai Y, Shao H, et al.
Journal of medical case reports 2025; (19(1)):373 doi:10.1186/s13256-025-05440-7.
PMID: 40731023 - 2
MRI Findings of Eosinophilic Fasciitis.
Kubincová M, Vanhoenacker FM
Journal of the Belgian Society of Radiology 2022; (106(1)):48 doi:10.5334/jbsr.2805.
PMID: 35651918 - 3
Idiopathic inflammatory myopathies: a comprehensive review, new concepts on diagnostic imaging and whole-body MRI.
Fagundes MDC, Gonçalves DVC, Shinjo SK, et al.
European radiology 2026; (36(5)):4218-4232 doi:10.1007/s00330-025-12230-8.
PMID: 41441994 - 4
Eosinophilic fasciitis difficult to differentiate from scleroderma: A case report.
Lan TY, Wang ZH, Kong WP, et al.
World journal of clinical cases 2023; (11(13)):3092-3098 doi:10.12998/wjcc.v11.i13.3092.
PMID: 37215414 - 5
Eosinophilic Fasciitis Without Skin Sclerosis.
Komori K, Rokutanda R
The Journal of rheumatology 2023; (50(7)):963-964 doi:10.3899/jrheum.220600.
PMID: 36455945 - 6
Eosinophilic Fasciitis in a 68-Year-Old Female.
Chittipolu S, Kennard JL, Nahar L
Cureus 2024; (16(2)):e53908 doi:10.7759/cureus.53908.
PMID: 38465140 - 7
The place of 18F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report.
Belfeki N, Louarn N, Chouchane I, et al.
Reumatismo 2021; (72(4)):252-254 doi:10.4081/reumatismo.2020.1353.
PMID: 33677952 - 8
Eosinophilic Fasciitis: Current and Remaining Challenges.
Mazilu D, Boltașiu Tătaru LA, Mardale DA, et al.
International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24031982.
PMID: 36768300 - 9
Lessons of the month 2: Connecting the clues: limb swelling and pain.
Prossor T, Sriskandarajah K, Vonberg FW, Dani M
Clinical medicine (London, England) 2020; (20(1)):105-106 doi:10.7861/clinmed.2019-0293.
PMID: 31941742 - 10
Eosinophilic fasciitis.
Lamback EB, Resende FS, Lenzi TC
Anais brasileiros de dermatologia 2016; (91(5 suppl 1)):57-59 doi:10.1590/abd1806-4841.20164683.
PMID: 28300895 - 11
Pediatric eosinophilic fasciitis: similarities and differences with adult forms.
César T, Giovannini D, Deroux A, et al.
European journal of pediatrics 2025; (184(2)):156 doi:10.1007/s00431-025-05981-5.
PMID: 39875648 - 12
Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study.
Yamamoto T, Ito T, Asano Y, et al.
The Journal of dermatology 2020; (47(12)):1391-1394 doi:10.1111/1346-8138.15561.
PMID: 32860239 - 13
Eosinophilic Fasciitis Illustrated by 18 F-FDG PET/CT.
Fevrier A, Dufour PA
Clinical nuclear medicine 2024; (49(4)):e188-e190 doi:10.1097/RLU.0000000000005094.
PMID: 38377376 - 14
Neuromuscular ultrasound findings in eosinophilic fasciitis: A case series and literature review.
Verenes M, Stone SL, Hobson-Webb LD, et al.
Muscle & nerve 2018; (58(2)):E15-E18 doi:10.1002/mus.26150.
PMID: 29679393
This page explains the diagnostic tests for Eosinophilic Fasciitis for educational purposes. Always consult your doctor or specialist to interpret your specific biopsy, MRI, or blood work results.
Get notified when new evidence is published on Eosinophilic fasciitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.